SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-060201
Filing Date
2023-11-07
Accepted
2023-11-07 16:00:38
Documents
72
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ctmx-20230930.htm   iXBRL 10-Q 3081973
2 EX-10.1 ctmx-ex10_1.htm EX-10.1 182664
3 EX-31.1 ctmx-ex31_1.htm EX-31.1 20063
4 EX-31.2 ctmx-ex31_2.htm EX-31.2 20259
5 EX-32.1 ctmx-ex32_1.htm EX-32.1 14816
6 EX-32.2 ctmx-ex32_2.htm EX-32.2 14865
  Complete submission text file 0000950170-23-060201.txt   10253515

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctmx-20230930.xsd EX-101.SCH 55295
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ctmx-20230930_cal.xml EX-101.CAL 41395
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ctmx-20230930_def.xml EX-101.DEF 238114
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctmx-20230930_pre.xml EX-101.PRE 367122
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ctmx-20230930_lab.xml EX-101.LAB 417974
66 EXTRACTED XBRL INSTANCE DOCUMENT ctmx-20230930_htm.xml XML 1889331
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37587 | Film No.: 231383533
SIC: 2834 Pharmaceutical Preparations